Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site release change rather than any modification to the clinical study information.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoChange DetectedA UI/visual refresh of the study page is observed; core study data such as eligibility, outcomes, and enrollment remain unchanged.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; no other visible changes to content or layout.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page shows a new Revision: v3.4.2 and the previous notices about government funding and operating status have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.